P-255: A randomized study of spotlight aq (sp aq) in youth with type 1 diabetes (T1D): interim analysis
P Connell, C Schweisberger, D Williams, K Garvey, A Wheelock, B Lockee, S Maccoll, K Barnard-Kelly, M ClementsAbstract
Introduction
Effective Type 1 diabetes (T1D) management requires addressing diverse biopsychosocial needs. The Spotlight AQ (SP AQ) pre-visit tool is designed to identify and visualize unmet physical, mental, and social needs to facilitate T1D management.
Objectives
We compared the clinical impact of SP AQ to standard of care (SOC) intake forms by evaluating changes in Hemoglobin A1c (HbA1c).
Methods
This randomized controlled study enrolled youth 16-25 years old with T1D across two pediatric clinics. Participants were assigned to use either SP AQ or SOC intake forms during two consecutive visits spaced three months apart. The primary outcome was mean change in HbA1c from baseline to follow up. Differences between SP AQ and SOC groups were analyzed using Pearson’s chi-square, Fisher’s exact, Wilcoxon rank-sum, or two-sample t-tests.
Results
This interim analysis included 66 youth (mean age 17.6±2.1 years) with 37 (56.1%) receiving SOC and 29 (43.9%) receiving SP AQ. The SOC group was 56.8% female and the SP AQ group was 69.0% male. No significant differences between groups were found regarding race (p=0.375) or ethnicity (p=0.409). The SP AQ group had a mean decrease in HbA1c% of -0.19±0.54, whereas the SOC group had a mean increase of 0.19±0.77 (p=0.0245).
Conclusions
Youth with T1D had significantly better HbA1c improvement using SP AQ versus SOC intake forms. SP AQ may improve pediatric clinic outcomes by providing specific resources and focused medical consultations.